About Cyclo Therapeutics, Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Pharmaceuticals
Location
Location
6714 NW 16th St, Gainesville, Florida, US
Description
Information
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is conducting a Phase 2b clinical trial using Trappsol® Cyclo™ intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. For additional information, visit the Company’s website: www.cyclotherapeutics.com.

Cyclo Therapeutics, Inc. Alternatives

Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about Cyclo Therapeutics, Inc.

What is Cyclo Therapeutics, Inc. email format?

The widely used Cyclo Therapeutics, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Cyclo Therapeutics, Inc. customer service number?

To contact Cyclo Therapeutics, Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more